Amoxicillin and Clavulanate potassium
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-098 -
Package NDC
69097-098-08 -
Package NDC
69097-098-43 -
Package NDC
69097-098-44 -
Application number
ANDA065431 -
SPL ID
07e2bc58-0782-4cba-9e8d-fb9c906ab71e -
SPL set ID
db25500a-90ee-429f-991f-da511cec7882 -
UNII
804826J2HU -
UNII
Q42OMW3AT8 -
RxCUI
617322
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- Amoxicillin and Clavulanate Potassium
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amoxicillin and Clavulanate potassium",
"splId": "07e2bc58-0782-4cba-9e8d-fb9c906ab71e",
"labels": [
{
"setId": "db25500a-90ee-429f-991f-da511cec7882",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db25500a-90ee-429f-991f-da511cec7882",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db25500a-90ee-429f-991f-da511cec7882"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "150 mL in 1 BOTTLE (69097-098-08)",
"package_ndc": "69097-098-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
},
{
"sample": false,
"description": "75 mL in 1 BOTTLE (69097-098-43)",
"package_ndc": "69097-098-43",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
},
{
"sample": false,
"description": "100 mL in 1 BOTTLE (69097-098-44)",
"package_ndc": "69097-098-44",
"identifierStatus": "well-formed",
"marketing_start_date": "20241028"
}
],
"productId": "69097-098_07e2bc58-0782-4cba-9e8d-fb9c906ab71e",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "69097-098",
"deaSchedule": null,
"genericName": "Amoxicillin and Clavulanate Potassium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMOXICILLIN",
"strength": "250 mg/5mL"
},
{
"name": "CLAVULANATE POTASSIUM",
"strength": "62.5 mg/5mL"
}
],
"applicationNumber": "ANDA065431",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241028",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0369097098445",
"0369097098087",
"0369097098438"
],
"unii": [
"804826J2HU",
"Q42OMW3AT8"
],
"rxcui": [
"617322"
],
"spl_set_id": [
"db25500a-90ee-429f-991f-da511cec7882"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-098_07e2bc58-0782-4cba-9e8d-fb9c906ab71e"